S. 3553 · 117th Congress

Agility in Manufacturing Preparedness Act

Stage
In committee
Introduced
2022-02-02
Latest action
2022-02-02 · Introduced in Senate

Summary

Agility in Manufacturing Preparedness Act

This bill requires the Department of Health and Human Services (HHS) to seek to contract with the National Institute for Innovation in Manufacturing Biopharmaceuticals to assess and make recommendations concerning U.S. capabilities for biopharmaceutical manufacturing and related matters. HHS must coordinate with the Biomedical Advanced Research and Development Authority on this contract.